EBV gp350 Envelope Protein Antibodies

Santa Cruz Biotechnology features a diverse variety of EBV gp350 Envelope Protein monoclonal antibodies for research applications. EBV gp350 Envelope Protein Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The EBV gp350 Envelope Protein plays a crucial role in the infection process of Epstein-Barr Virus (EBV), facilitating viral entry into host cells by binding to the CD21 receptor. Understanding EBV gp350 Envelope Protein function is essential for investigating EBV pathogenesis, which is associated with infectious mononucleosis and various malignancies. Research focusing on EBV gp350 Envelope Protein can reveal important insights into viral behavior and potential therapeutic targets. Investigating EBV gp350 Envelope Protein interactions helps scientists understand the molecular mechanisms of viral infection and host cell response. Exploring EBV gp350 Envelope Protein dynamics contributes to developing new therapeutic strategies against EBV-related diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EBV pathogenesis and potential treatments.